Navigation Links
Major NIMH research project to test approaches to altering the course of schizophrenia
Date:7/21/2009

The National Institute of Mental Health (NIMH) is launching a large-scale research project to explore whether using early and aggressive treatment, individually targeted and integrating a variety of different therapeutic approaches, will reduce the symptoms and prevent the gradual deterioration of functioning that is characteristic of chronic schizophrenia.

The Recovery After an Initial Schizophrenia Episode (RAISE) project is being funded by NIMH with additional support from the American Recovery and Reinvestment Act (ARRA). RAISE is a model example of how money from the Recovery Act can accelerate science related to public health problems and potentially benefit those citizens most in need.

"This new initiative will help us determine whether intervention that is started early, incorporates diverse treatment and rehabilitation approaches, and is sustained over time, can make it possible for more people with schizophrenia to return successfully to work and school," said NIMH Director Thomas R. Insel, M.D. "Moreover, the interventions being tested will be designed from the outset to be readily adopted in real-world health care settings and quickly put into practice."

Despite the availability of moderately effective treatments, such as antipsychotic medications and various psychosocial interventions, people with schizophrenia often do not receive treatment until the disease is already well-established, with recurrent episodes of psychosis, resulting in costly multiple hospitalizations and disabilities that can last for decades. Periods of unemployment, homelessness, and incarceration are common, making schizophrenia a costly disease for individuals, their families, and the community at large.

RAISE will test approaches that involve intervening immediately upon first diagnosis, systematically incorporating the range of options that are now available in a more piecemeal fashion to people with schizophrenia. These
'/>"/>

Contact: Charlotte Armstrong
NIMHpress@nih.gov
301-443-4536
NIH/National Institute of Mental Health
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. 2009 National Ergonomics Conference Schedule Announced, Focus on Productivity & Profitability With Reduced Workforces, All Major Sponsors Renew & New Exhibitors Join the Expo
2. Avoiding Hysterectomy: Major Interventional Radiology E-collection Info Available
3. Celesio Acquires Majority Stake in Number One Brazilian Pharmaceutical Wholesaler Panpharma
4. Volcano Achieves Major Milestone in Japan Direct Sales Initiative With Signing of Termination Agreement With Goodman
5. Major Firms Eyeing CBMS Development of New Glaucoma Treatment
6. New Urine Drug Test to Detect for 6 Major Drugs, Now Available at Drugstore.com -- 'DrugConfirm' Is a New Revolutionary Urine Drug Test
7. Extreme Heat Causes Major Health Problems for Older Adults
8. Contract Talks for 1,800 Security Officers at Kaiser Permanente Break Down - Major Cuts to Worker Healthcare are at Issue
9. Nation Takes a Big Step Toward Learning Which Medical Treatments Work Best, a Major Advance in Fixing Our Broken Health-Care System
10. Major New Report Establishes Effective Methods of Enhancing and Preserving Brain Power as We Age
11. Major study highlights weight differences among 3-19 year-olds with type 1 and 2 diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)...ep eating under control, expert says , ,...eason means you,ll be faced with a seemingly endle...mply give in and eat too much, others deny themsel... navigate between overindulgence and deprivation, ...onsult Services at Brigham and Women,s Hospital in...
(Date:11/22/2009)...The holiday season is filled with get-togethers wi...us. It can also be stressful and tiring at times. ...igue, and high fat foods -- factors that can, over...e National Foundation for Cancer Research has deve...ure a happier, more healthful holiday season, and ...
(Date:11/22/2009)... 21 Congressman Chaka F...he United States Senate,s vote tonight to proceed ..., "Senators Arlen Specter and Bob Casey deserve...ns for casting stand-up, critical votes in the Sen...ffordable Health Care Reform legislation to full d...
(Date:11/21/2009)...v. 21 DNC Chairman Tim ...ate voted to begin full debate of health insurance...scom.com/cgi-bin/prnh/20080519/DNCLOGO ) ,, "...e road to enacting health insurance reform. By cle...now have an opportunity to debate the health refor...
(Date:11/21/2009)... 21 Milvia Lopez, by her attorney ...y filed suit, in Supreme Court, New York County, b...that while Ms. Lopez underwent a routine transesop...SPITAL , doctors used an HIV infected scope exposi...several hours after being discharged from the proc...
Breaking Medicine News(10 mins):Health News:Go Healthy, Not Hungry for Holiday Eating 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 3Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2
...ep in understanding how the nervous system and the...in Institute for Medical Research have identified ...the spleen communicate. , ...nstein Institute for Medical Research have identi...
...to safety; group seeks legislative help , ...y can be nearly silent, hybrid cars pose a serious...impaired people, says the American Council of the ...sually impaired learn to rely on their hearing and...
...thocyanidins are natural, plant-based color...Calif., July 21 ChromaDex Corp., (OTC,Bulletin Bo...ndards and,contract research, announced today its ... the University at Buffalo (SUNY,Buffalo), to prod...
... Inc, (http://www.inutrition.com ) and InterACTIVE...com ) subsidiaries of Natural Nutrition, Inc, (OTC...mpanies have inked an,agreement with actor John O,...rnet video campaign. Mr. O,Hurley is bringing,his ...
...c and Orthopedic Hospital of Chicago offers inform.... Available as a laminated card or downloadable p...sks, including knee-specific strengthening exercis...ament (ACL) every year. That's double the nu...
...ss surgery, researchers say , , FRIDAY, Ju...e grown in mice the kind of functioning heart bloo... operations. , One ultimate goal is to replace som... hearts that need more oxygen, said Juan M. Melero...
Other Medicine News:Health News:Embargoed Until Monday, July 21 at 5 p.m. EST; Scientists Figure Out How the Immune System and Brain Communicate to Control Disease 2Health News:Embargoed Until Monday, July 21 at 5 p.m. EST; Scientists Figure Out How the Immune System and Brain Communicate to Control Disease 3Health News:Hybrid Cars Pose Risk to Blind, Visually Impaired 2Health News:ChromaDex Licenses Green Chemistry Technology to Manufacture a New Class of Super Fruit Compounds 2Health News:ChromaDex Licenses Green Chemistry Technology to Manufacture a New Class of Super Fruit Compounds 3Health News:iNutrition Signs John O'Hurley to Launch New Internet Video Campaign 2Health News:Complimentary Sports Injury Prevention Pamphlet for Women Offered by NOHC of Chicago 2Health News:Complimentary Sports Injury Prevention Pamphlet for Women Offered by NOHC of Chicago 3Health News:Heart Blood Vessels Grown in the Lab 2
(Date:11/20/2009)...wswire-FirstCall/ -- Biotel Inc. (OTC Bulletin Boa...ended September 30, 2009 with net earnings of $128...3,263,000. This compares to net earnings of $328,...,168,000 for the first quarter of last year. ,,...resident and CEO Steve Springrose said: "Biotel en...
(Date:11/20/2009)... Smith & Nephew ( SNN...ounce the signing of a technology development cont...that may lead to the creation of a fracture fixati...of the limbs of soldiers who sustain battlefield i...earch Projects Agency (DARPA), the central researc...
(Date:11/19/2009)...Newswire/ -- In response to an ever-increasing num...dicines, Operation Pangea II, involving 24 countri...th Organization,s International Medical Products A... the dangers of buying medicines online. ,, The...of arrests and the seizure of thousands of potenti...
Breaking Medicine Technology:Biotel Announced Profitable First Quarter Ended September 30, 2009 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Dynatronics Will Request Hearing With Nasdaq Regarding Listing Status 5522 1Paradigm shift needed to combat drug resistance 59596 1Paradigm shift needed to combat drug resistance 59596 2Physical therapists play integral role in prevention risk reduction and treatment of lymphedema 59594 1Physical therapists play integral role in prevention risk reduction and treatment of lymphedema 59594 2Physical therapists play integral role in prevention risk reduction and treatment of lymphedema 59594 3
...hase II Results of Roche and Ipsen,s First Once-We...betes Association Meeting -, NUTLEY, N.J., June 1...es drug taspoglutide (R1583) has been shown to pro...nd weight loss after only,eight weeks of treatment...supports entry into Phase III. Taspoglutide, origi...
...l Results Expected in Q3 2008, Conference Call to...ern Time, MOUNTA...nc. (Nasdaq: ALXA ) announced today that it has c...trial with AZ-004 (Staccato(R),loxapine). AZ-004 i...for,the treatment of acute agitation in patients w...
Other Medicine Technology:Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 2Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 3Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 4Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 5Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 6Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 2Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 3Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 4Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 5Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 6Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 7
Straight Iris Scissors (Ring Handle)
Surpass Superfusion
...es its hallmark 50 and 100 ms scans to perform tru...scan protocols and proprietary cardiac analysis so...targets and two x-ray detector rings to image the ...ial perfusion and wall motion. The EBT C300 also s...
Corneal Scissors (Westcott Straight Tenotomy Scissors)
Medicine Products: